Chitin Derivative‐Based Detachable Microneedles for Effective Treatment of Androgenic Alopecia
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Jiaxue Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Alopecia, Chitin, Microneedle Drug Delivery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province.
Abstract (Originalsprache)
Androgenic alopecia (AGA) is the most common type of hair loss in clinical practice, which not only compromises scalp physiology but also induces psychological comorbidities. Despite its high prevalence, current therapeutic interventions for AGA remain constrained by prolonged treatment durations, notable safety risks, and prohibitive expenses. To address these limitations, we engineered detachable microneedles incorporating TEMPO‐oxidized chitin derivatives (CD MNs), which demonstrated unprecedented hair regenerative capacity. In C57BL/6j AGA models, CD MNs induced 71.56% ± 14.20% hair regrowth density at day 16 (vs. 32.23% ± 14.55% for 5% minoxidil, t he current clinical gold standard). Ex vivo AGA hair follicle exhibited 0.93 ± 0.15 mm hair shaft elongation under chitin derivatives treatment within 5 days, which is comparable to minoxidil. Mechanistic profiling via single‐cell RNA sequencing identified CD MNs mediated suppression of lysosomal hydrolases and membrane proteins, indicating autophagy potentiation. Further ex vivo studies confirmed that chitin derivatives promoted hair growth by activating the hair follicle autophagy. Notably, the microneedle system exhibited no detectable dermal or visceral toxicity. To our knowledge, this study is the first to report the anti‐AGA activity of chitin derivatives. Our findings established a robust theoretical foundation and preclinical validation for chitin‐based biomaterials as next‐generation AGA therapies, offering a safe, cost‐effective alternative to conventional therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China.
- The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
ORCID-Profile: Qingqing Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shaanxi Province
Zitieren
APA
Zhang, J., Zhang, Y., Yang, Y., Bai, W., Wang, Z., Yang, C., Zhang, P., Li, Q., Zhang, J., & Ma, J. (2026). Chitin Derivative‐Based Detachable Microneedles for Effective Treatment of Androgenic Alopecia. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504691
Vancouver
Zhang J, Zhang Y, Yang Y, Bai W, Wang Z, Yang C, et al. Chitin Derivative‐Based Detachable Microneedles for Effective Treatment of Androgenic Alopecia. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504691
BibTeX
@article{Zhang2026,
author = {Zhang, Jiaxue and Zhang, Yijia and Yang, Ying and Bai, Wenhui and Wang, Zhiqi and Yang, Chen and Zhang, Peipei and Li, Qingqing and Zhang, Jiye and Ma, Jia},
title = {Chitin Derivative‐Based Detachable Microneedles for Effective Treatment of Androgenic Alopecia},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504691}
}
EUVIMED